Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6241
|
355
|
0.100 |
None |
1.000 |
14 |
|
2004 |
2019 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2314
|
611
|
0.080 |
None |
1.000 |
8 |
|
1996 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.060 |
None |
1.000 |
6 |
|
2006 |
2015 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
937
|
50
|
0.060 |
None |
1.000 |
6 |
|
2001 |
2018 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1126
|
103
|
0.050 |
None |
0.800 |
5 |
|
2002 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6345
|
327
|
0.060 |
None |
0.833 |
5 |
|
2004 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.040 |
None |
1.000 |
4 |
|
2007 |
2017 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1555
|
233
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2017 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
757
|
35
|
0.350 |
None |
1.000 |
4 |
|
2008 |
2020 |
LEPTIN DEFICIENCY OR DYSFUNCTION
|
disease |
|
Disease or Syndrome
|
15
|
|
0.040 |
None |
1.000 |
4 |
|
2018 |
2019 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1673
|
96
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2018 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2018 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1293
|
193
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2019 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
605
|
40
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2018 |
Endometriosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
1031
|
207
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2013 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2140
|
78
|
0.370 |
None |
1.000 |
3 |
|
2002 |
2014 |
Monogenic Obesity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Sign or Symptom
|
11
|
1
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2018 |
Isolated somatotropin deficiency
|
disease |
|
Disease or Syndrome
|
96
|
15
|
0.130 |
None |
1.000 |
3 |
|
2011 |
2016 |
Hypogonadotropic hypogonadism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
78
|
18
|
0.330 |
None |
1.000 |
3 |
|
1999 |
2015 |
Anorexia Nervosa
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
186
|
52
|
0.060 |
None |
1.000 |
3 |
|
2002 |
2020 |
Klinefelter Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
148
|
18
|
0.030 |
None |
1.000 |
3 |
|
1999 |
2015 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1736
|
316
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2016 |
Fatty Liver Disease
|
disease |
|
Disease or Syndrome
|
740
|
41
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2017 |
Multiple Sclerosis, Relapsing-Remitting
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
205
|
7
|
0.030 |
None |
1.000 |
2 |
|
2004 |
2020 |
Meningioma, benign, no ICD-O subtype
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
404
|
30
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2018 |